1. Hoskins W (1993) Primary surgical management of advanced epithelial ovarian cancer. In: Rubin and Sutton, eds. Ovarian Cancer. New York: McGraw-Hill, pp. 241–253.
2. Griffiths CT (1975) Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 42:101–104.
3. Conte PF, Bruzzone M, Chiara S, Sertoli MR, Daga MG, Rubagotti A, Conio A, Ruvolo M, Rosso R, Santi L, et al. (1986) A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. J Clin Oncol 4:965–971. [Published erratum appears in J Clin Oncol 1986;4:1284.]
4. Delgado G, Oram DH, Petrilli ES (1984) Stage III epithelial ovarian cancer: The role of maximal surgical reduction. Gynecol Oncol 18:293–298.
5. Neijt J, ten Bokkel Huinink W, van der Burg M, van Oosterom A, Willemsen P, Heintz A, van Lent M, Trimbus J, Bouma J, Vernorken J, van Houwelingen J (1987) Randomized trial comparing two combination chemotherapy regimens (CHAP-5 vs. CP) in advanced ovarian carcinoma. J Clin Oncol 5:1157–1168.